Results 251 to 260 of about 29,580 (292)

Case Report: Successful treatment of steroid-refractory graft-vs.-host disease following bilateral lung transplantation. [PDF]

Front Transplant
McCormick BJ, Rusanov V, Tao Z, Kaleekal T, Wille K, Espinoza-Gutarra MR.   +5 more
europepmc   +1 more source

Real-World Use of Topical Ruxolitinib in Vitiligo: Retrospective Cross-Sectional Mixed Methods Infodemiology Study of the r/Vitiligo Subreddit.

J Med Internet Res
Kirchberger MC, Berking C, Eisenried A.
europepmc   +1 more source

Clinical and disease characteristics from REVEAL at time of enrollment (baseline): Prospective observational study of patients with polycythemia vera in the United States [PDF]

, 2018
Boccia, Ralph V, Colucci, Philomena, Grunwald, Michael R, Mesa, Ruben, Oh, Stephen T, Paranagama, Dilan, Parasuraman, Shreekant, Stein, Brady L   +7 more
core   +1 more source

JAK1/2 Inhibition Delays Cachexia and Improves Survival through Increased Food Intake

Dantas E, Murthy A, Kim J, Ahmed T, Ahmed M, Perrier T, Ramsamooj S, Nathoo I, Kniess Debarba L, Lima Queiroz A, Li S, Ersoy B, Ferrer M, Goldstein I, Gao J, Lam T, Nagler M, Malbari M, Altorki N, Cararo Lopes E, Gomez Jenkins M, Das T, Jamal-Hanjani M, White E, Janowitz T, Goncalves MD.   +25 more
europepmc   +1 more source

Preclinical efficacy of tasquinimod-based combinations in advanced myeloproliferative neoplasms in blastic phase. [PDF]

Blood Adv
Fiskus W, Masarova L, Mill CP, Birdwell CE, Das K, Hou H, Davis JA, Jain A, Malovannaya A, Manshouri T, Dunbar A, Sharma S, Kadia TM, DiNardo CD, Bose P, Pemmaraju N, Loghavi S, Su X, Rampal RK, Törngren M, Bhalla KN.   +20 more
europepmc   +1 more source

Revisiting Janus Kinase Inhibitors in Hospitalized COVID-19: Evidence for Baricitinib's Superiority and the Absence of a Class Effect. [PDF]

J Inflamm Res
Gu L, Lin J, Yue J, Liu Z, Huang JA.
europepmc   +1 more source

Efficacy and Safety of Ruxolitinib Cream for the Treatment of Moderate to Severe Chronic Hand Eczema: Top-Line Results From a 16-Week, Multicenter, Randomized, Double-Blind Study

Matthew Zirwas, Philippa Halden, Zhihong Lai, YuTzu Kuo, Haq Nawaz, Linda Stein Gold   +5 more
openalex   +1 more source

Advancements in myelofibrosis management: a comprehensive analysis of Ojjaara (Momelotinib) therapy and clinical perspectives. [PDF]

Ann Med Surg (Lond)
Basaria AAA, Tariq R, Ahsan A, Ahsan AA, Wei CR, Bavurhe RF, Murhula JM, Bisimwa J, Akilimali A.   +8 more
europepmc   +1 more source

Remestemcel-L-rknd (Ryoncil): the first approved cellular therapy for steroid-refractory acute GVHD. [PDF]

Blood
Etra A, Ferrara JLM, Levine JE.
europepmc   +1 more source